VOICED : China aprueba "con condiciones" su primera vacuna contra el covid-19

China has conditionally approved the Sinopharm COVID-19 vaccine, claiming 79% efficacy. The approval follows rigorous evaluations, concluding that the vaccine's benefits outweigh potential risks. Conditional marketing allows public access before clinical trials are complete, provided efficacy is indicated. The Health Ministry plans to vaccinate risk groups and aims for 60-70% population immunization. The vaccine will be free for all citizens.

What is the reported efficacy of the Sinopharm COVID-19 vaccine?

• 70%

• 79%

• 90%

• 85%

What does conditional marketing allow for the Sinopharm vaccine?

• Permanent approval without conditions

• Use before clinical trials are fully completed

• Approval without any testing

• Immediate global distribution

Which groups are prioritized for vaccination according to the Ministry of Health?

• Children and teenagers

• Healthcare workers only

• High-risk groups like the elderly and those with chronic diseases

• All citizens at once

What percentage of the Chinese population needs to be immunized to ensure public safety?

• 30-40%

• 50-60%

• 60-70%

• 80-90%

What commitment did the viceminister make regarding the vaccine?

• It will be distributed internationally first

• It will be available only in urban areas

• It will be free for all citizens

• It will be sold at a reduced price